End the Vaccine Carveout Act
End the Vaccine Carveout Act
Plain Language Summary
# End the Vaccine Carveout Act - Summary **What the Bill Would Do:** This bill aims to remove a legal exemption that shields vaccine manufacturers from certain lawsuits. Currently, vaccine makers have broad immunity from liability claims related to vaccine-related injuries under the National Childhood Vaccine Injury Act (NCVIA). This bill would eliminate or reduce that protection, allowing individuals who believe they've been harmed by vaccines to sue manufacturers directly in civil court. **Who It Affects:** The primary groups affected would be vaccine manufacturers (pharmaceutical companies), individuals who believe they've suffered vaccine injuries, and potentially the broader vaccine distribution system.
The change could also indirectly affect vaccine availability and pricing if manufacturers face increased litigation costs. **Current Status:** As of now, the bill is in committee, meaning it has been introduced but has not advanced to a full House vote. It has not yet been scheduled for hearings or floor consideration. The bill would require approval from relevant committees and both chambers of Congress to become law.
Latest Action
Referred to the House Committee on Energy and Commerce.